Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the treatment of active or high clinical activity score (CAS) Thyroid Eye Disease (TED) ...

The biotech industry is poised for significant growth, fueled by advanced technologies, the increased commercialization of ...

USA: The results of the FOREMOST trial indicate that apremilast is effective for patients with early psoriatic arthritis (PsA ...

The mucocutaneous and articular clinical phenotype is the most common presentation of Behçet’s disease (BD).1 Current ...

With more than 300 patients in the trial, dubbed FOREMOST, 33.9% of those assigned to apremilast achieved minimal disease ...

Improvements in 2 patient-reported outcome measures were observed among patients with psoriasis treated with deucravacitinib vs placebo or apremilast.

Amgen (NASDAQ: AMGN) today announced the presentation of new data across its broad oncology pipeline and portfolio at the ...

NexoBrid Approval Expanded to Include Pediatric Burn Patients Otezla (apremilast) Phosphodiesterase type 4 inhibitor Treatment of pediatric patients 6 years of age and older weighing at least 20kg ...

Finding an effective treatment for psoriatic disease (PD) often requires trial and error. Because people experience PD differently, there's no one-size-fits-all ...

Celgene’s latest deal comes as it celebrates the sale of its blockbuster psoriasis therapy Otezla (apremilast) to Amgen for an impressive $13.4 billion, clearing the way for the $74 billion ...

September 3, 2024 • A beloved beluga whale with a mysterious past was found dead in the waters of Norway over the weekend. Admirers are paying tribute as authorities investigate.

Since Sunday, Tropical Storm Enteng (international name: Yagi) has brought rains and caused heavy flooding in Metro Manila and its neighboring cities, with Signal No. 2 raised in nine areas in Luzon.